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A new miniaturized glucose oxidase based needle-type glu¬
cose mlcrosensor has been developed for subcutaneous glu¬
cose monitoring. The sensor Is equivalent In shape and size
to a 26-gauge needle (0.45-mm o.d.) and can be Implanted
with ease without any Incision. The novel configuration
greatly facilitates the deposition of enzyme and polymer films
so that sensors with characteristics suitable for In vivo use
(upper limit of linear range > 15 mM, response time < 5 mln,
and sensitivity yielding a 5:1 signal-to-background ratio at
normal basal glucose levels) can be prepared In high yield
(>60%). The sensor response is largely Independent of ox¬
ygen tension In the normal physiological range. It also ex¬
hibits good selectivity against common interferences except
for the exogenous drug acetaminophen.
INTRODUCTION
Development of a glucose oxidase based glucose sensor for
continuous monitoring of physiological glucose levels was first
proposed more than 15 years ago (1). These sensors were
incorporated into a macroscopic artificial pancreas and
measured diluted blood from an intravenous catheter. Such
an arrangement obviously is not practical for ambulatory
patient monitoring. Thus, as an alternative, Shichiri proposed
the monitoring of glucose in subcutaneous tissue (2). Sub¬
sequently, numerous other publications (3-11) have focused
on the development of needle-type glucose sensors suitable
for subcutaneous monitoring. Several studies (5,12-14) have
confirmed that under steady-state conditions the apparent
subcutaneous glucose levels are identical with those of blood
glucose, thus making this site effective. Also, in a recent paper,
it has been demonstrated that it is possible to control plasma
glucose in diabetic dogs during a glucose load by using a
closed-loop insulin delivery system based on subcutaneous
glucose measurement (15). This is in agreement with the
demonstrated short lag time between the changes in glucose
concentration in subcutaneous tissue and in blood (4, 5).
Intravascular systems have been shown to function safely in
a limited number of diabetic dogs (16).
Several enzymatic glucose sensors (2, 4-9) that have been
utilized with some success in the past for subcutaneous
monitoring of glucose are compared in Table I. As noted,
most of the sensors are too large to be suitable for in vivo
monitoring if frequent changes of the sensor are required. For
such applications, a miniaturized sensor (less than 0.5 mm in
diameter) is needed that can be conveniently implanted by
*To whom all correspondence should be sent.
Table I. Glucose Sensors Used for Subcutaneous Glucose
Monitoring
shape o.d., mm determinant site ref
needle type (blunt) 1.0 h202 2,4
needle type 2.5 h2o2 5
needle type 1.3 dimethylferrocene 6
needle type 0.5 dimethylferrocene 7
needle type 0.35 h202 8
planar 1.0 (width) h2o2 9
the patient. A sensor with an outer diameter of less than 0.5
mm will be acceptable considering that the needles used by
diabetics for their daily insulin injections are in the 0.4-mm-
diameter range. The fabrication of such devices usually re¬
quires the deposition of several layers of polymer and enzyme
directly on the sensor. The miniaturization of the sensor,
therefore, is not trivial.
The configuration of the sensor is a function of whether the
glucose oxidase catalyzed oxidation of glucose is monitored
by measuring H202, 02, or a redox mediator such as di-
methylferrocene. All configurations have their advantages and
disadvantages. The most successful oxygen-detecting sensor
has been developed by Gough and co-workers (16). Because
oxygen is monitored, a low applied potential for amperometric
detection is required. The potential is in a region where few
endogenous electroactive species can interfere. Also, the
gas-permeable hydrophobic layer over the electrode prevents
access to the electrode surface of small interfering polar
species. The signal of merit is the difference between the
ambient oxygen level and the level attained as a result of
oxygen depletion by the enzymatic reaction. To obtain this
differential signal, basal ambient oxygen levels must be as¬
sumed-constant or must be monitored. The hydrogen peroxide
based sensor is more easily fabricated, but it suffers in prin¬
ciple from the poor electrochemical selectivity and the de¬
pendence of response on ambient oxygen. These problems
can be largely corrected by using semipermeable membranes
with specific transport properties. For example, if the ratio
of glucose-to-oxygen flux can be decreased, this can result in
insensitivity of the sensor response to oxygen tension (17).
Suitably designed membranes can also screen out substances
that may interfere with the electrochemical response (18,19).
Because the reduced enzyme is fairly easy to oxidize, mediators
such as ferrocene have been used in place of oxygen as the
electron acceptor. Again the applied potential can be in a
region where few endogenous electroactive species can in¬
terfere. In principle, such a sensor should also show almost
complete insensitivity to variations in oxygen tension, but this
is not always guaranteed. Oxygen can affect the response
indirectly by competing with the mediator for the reduced
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Figure 1. Schematic diagram of the sensor: (a) Teflon-coated Pt-Ir
wire (0.25-mm o.d.), (b) Teflon tip, (c) sensing cavity (1-mm length),
(d) Ag/AgCI reference electrode, (e) heat-shrinkable tubing, (f) refer¬
ence electrode terminal, (g) working electrode terminal.
enzyme. These sensors suffer from a lack of long-term stability
and possible toxicity of the mediator.
We have designed a needle-type hydrogen peroxide based
amperometric sensor equivalent in shape and size to a 26-
gauge needle (0.45-mm o.d. overall, 0.25-mm o.d. for sensing
portion). The sensing element is located at the side of the
sensor in the form of a cavity (Figure 1). A coaxial reference
electrode of high surface area is also included. A critical
property of the stated geometry is that it permits easy de¬
position of the several polymeric films, providing uniform
performance and better reproducibility of the sensor's final
characteristics. The miniature needle shape is a conveinient
design for a subcutaneous sensor and is believed to minimize
inflammation (20). These sensors have been demonstrated
to work reliably for up to 20 days when implanted in the
subcutaneous tissue of a rat (21). This paper, however, will
deal only with the design and the in vitro evaluation of these
sensors. The various factors that can affect the in vivo per¬
formance of the sensor such as the influence of temperature
and H202 on enzyme stability, 02, pH dependence of the
response, and selectivity toward possible interferents are better
studied in vitro. A thorough understanding of in vitro re¬
sponse is very important for the correct interpretation of the
in vivo results.
EXPERIMENTAL SECTION
Equipment. Amperometry was performed by using a Bioa-
nalytical Systems, Inc. (W. Lafayette, IN), Model LC4A am¬
perometric detector. Current-time curves were recorded on a
Kipp and Zonen Model BD 40 strip-chart recorder.
Materials. High-purity glucose oxidase (EC 1.1.3.4) (242000
units/g) was obtained from Biozyme Laboratories International
Ltd. (San Diego, CA). Bovine serum albumin (Fraction V, 98-99%
albumin), bovine IgG, and bovine fibrinogen (Type 1-S) were all
products of Sigma. Bovine serum was purchased from Hyclone
Laboratories, Inc. (Logan, UT), and was diluted to 80% with
phosphate-buffered saline (PBS), pH 7.4, before using.
All buffer solutions were prepared with water from a Barnstead
Nanopure II system. PBS, pH 7.4, was prepared from phosphate
salts (0.1 M) and sodium chloride (0.15 M) with sodium azide (0.1
g/L) as preservative. A glucose stock solution (0.5 M) was pre¬
pared in PBS and was allowed to mutarotate overnight at room
temperature. It was subsequently stored at 4 °C. L-Ascorbic acid
(Fisher) and L-cysteine (Sigma) solutions were prepared just before
use, as they are subject to oxidative decomposition in solution.
Polyurethane (SG 85A) was obtained from Thermedics, Inc.
(Woburn, MA). Cellulose acetate (39.8% acetyl content) was
obtained from Aldrich. All solvents used for polymer solutions
were of analytical grade. The glutaraldehyde solution used in
immobilization process was purchased from Aldrich as a 25%
aqueous solution.
Fabrication of the Sensor. Indicating Electrode. One end
of a 10-cm-long Medwire Corp. (Mount Vernon, NY) Teflon-
coated platinum-iridium (Pt-Ir) wire (0.25-mm o.d.) was stripped
to form a cavity as shown in Figure 1. This was achieved by first
putting a circular cut on the Teflon coating (35-^m thickness)
with a standard paper cutter 4 mm from the tip and then pulling
the Teflon out to create a cavity of about 1-mm length. The excess
Teflon at the tip was trimmed off with the cutter, and the tip
was sealed off with silicone rubber glue (Dow Corning Corp.,
Midland, MI).
Reference Electrode. The reference electrode was formed on
the Teflon surface, 1.5 mm above the exposed Pt-Ir surface. A
thin silver wire (0.1-mm o.d., 15-cm length) was tightly wrapped
A
Figure 2. Expanded view of the sensing cavity: (a) cavity holding a
drop of enzyme solution; (b) multilayer structure.
around the Teflon surface covering about 4 mm of its length. A
wire wrapping tool (Gardner-Denver) was utilized for this purpose.
The straight section above the wrapped silver wire was covered
with 5-cm-long, 1.5-mm-o.d. heat shrinkable Teflon tubing (Zeuss
Industrial Products, Inc., Raritan, NJ). Protruding lengths of
silver wire and Pt-Ir wire were left uncovered for electrical contact.
A heat gun (Fisher) operating at 600 °C was employed for
shrinking the Teflon tubing. A layer of silver chloride was formed
by passing current (0.4 mA/cm2) for 60 min through the wrapped
silver wire while it was dipped in a stirred 0.1 N HC1 solution.
The reference electrode was rinsed with deionized water for 6 h.
The Ag/AgCI reference electrodes prepared in this manner showed
potentials of 64 ± 3 mV (n = 10) in 0.15 M NaCl at 37 °C vs
Ag/AgCI (3 M NaCl).
Enzyme Immobilization. The exposed portion of the Pt-Ir
wire acted as the starting point for the construction of the sensing
element. The bare surface was first degreased by washing with
acetone. It was then rinsed with deionized water and dried in
a cold air stream before polymer deposition.
The lower part of the sensor (Figure 1—from arrow x to the
distal end of sensor) was dipped into 5% cellulose acetate (CA)
solution in 50% acetone-50% ethanol for 10 s and was withdrawn
slowly. It was then exposed to the vapor above the CA solution
for 5 s and was dipped again into the CA solution for 10 s. The
sensor was removed and dried in air at room temperature (23 °C)
for 1 min and then placed in deionized water for 6 h to permit
displacement by water of entrapped solvent in the membrane
pores.
A small volume (1 mL) of GOx solution (20 mg/mL in 0.1 M
PBS) was held at the tip of a wire (0.5-mm o.d.) in the form of
a droplet and was transferred to the sensing element (cavity)
simply by moving it through the droplet (Figure 2A). The enzyme
solution was allowed to dry for 30 min at room temperature while
holding the sensor horizontally. To immobilize the enzyme, either
the sensor was exposed to the glutaraldehyde vapor generated
from 0.5 mL of 25% glutaraldehyde solution placed at the bottom
of an enclosed 4-mL glass bottle for 40 min at room temperature
or a small volume (1 /iL) of 2% glutaraldehyde solution was
transferred to the cavity and was allowed to react with the ad¬
sorbed enzyme for 1 h at room temperature. The sensor was rinsed
thoroughly in deionized water and dried in air for 1 h. With some
care, the enzyme deposition can be restricted only to the cavity.
Outer Protective Layer. In order to complete the preparation
of the sensor, the whole sensor (Figure 1—from arrow y to the
distal end of sensor) was dip coated with 5% polyurethane (PU)
solution in 98% tetrahydrofuran (THF)-2% dimethylformamide
(DMF). The PU solution (10 nL) was held in a wire loop (2-mm
i.d.), and the sensor was passed through the loop lengthwise with
the sensing end entering first. This left an apparently uniform
polymer film on the sensor (Figure 2B) as viewed by using an
optical microscope. The sensor was dried in air for 6 h at room
temperature and then left in 0.1 M phosphate-buffered saline
(PBS), pH 7.4, for 72 h to permit outer membrane conditioning.
It was possible to increase the thickness of the PU membrane if
the desired linear range was not obtained after the first coating.
This was accomplished by repeating the above process.
In Vitro Calibration of the Sensor. The sensor was dipped
into a temperature and oxygen tension-controllable cell containing
10 mL of stirred PBS, pH 7.4 (37 °C, air-saturated), and a po¬
tential of +600 mV (for hydrogen peroxide detection) was applied
between the working and the reference/counter electrodes. The
background current was allowed to stabilize for at least 30 min.
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The calibration of the sensor was carried out by adding increasing
amounts of glucose (or an interfèrent) to the stirred buffer. The
current was measured at the plateau (steady-state response) and
was related to the concentration of the analyte.
The sensors were usually stored in 0.1 M PBS, pH 7.4, at room
temperature during the stability studies. However, it was verified
that it is also possible to store sensors dry at room temperature.
The dry sensors (n = 10) usually recovered their original sensi¬
tivities and linearities within 2 h after they were put back into
the buffer.
Ethylene Oxide (EO) Sterilization. The sensors were sealed
into gas sterilization pouches and were exposed to ethylene oxide
gas for 12 h in a gas sterilizer (Millipore Corp., Bedford, MA).
The sensors were left in the pouches until they were needed. In
all cases, the sensors were allowed to degas for at least 48 h to
get rid of the adsorbed EO before use. This procedure permits
sterilization without loss of sensor performance. These results
are described elsewhere (22).
RESULTS AND DISCUSSION
Sensor Preparation. The CA membranes were formed
by using a wet process. Dip-coated membranes were allowed
to partially dry in air, after which they were submerged in
water to permit displacement of residual solvent. The end
product was a water-swollen membrane. The porosity of these
membranes was controlled by their water content, which in
turn was a function of the concentration of ethanol (nonsolvent
pore former) in the casting solution containing CA and acetone
(23, 24). The membranes prepared from a CA solution in a
50% acetone-50% ethanol mixture with a 1-min drying period
prior to their immersion in water showed high permeability
and good selectivity against small anions. The hydrogen
peroxide to ascorbate response ratio ranged between 3 and
10 (relative response corresponding to 0.1 mM solutions of
each), compared to the ratio of unity for a membrane showing
no permselectivity. The permselective nature of CA mem¬
branes is well-known and has been utilized previously to se¬
lectively remove interference from anions such as ascorbate
and urate (18, 25).
One of the most crucial parts of the sensor fabrication is
the design of the semipermeable outer membrane. The outer
membrane, if properly selected, prevents degradation of the
sensor in the biological environment and also decreases the
glucose mass transfer relative to oxygen, leading to increased
linearity and insensitivity to fluctuations in oxygen tension
(26). Considering the many functions this membrane per¬
forms, it is reasonable to assume that a barrier with stable
and reproducible transport properties is essential for proper
functioning of the sensor. A large variety of membranes has
been suggested for this purpose, including poly(dimethyl-
siloxane) (3), polyurethane (2, 4), cellulose acetate (27), and
Nafion (28). There is no general agreement on the optimal
membrane material. PU was selected for the present work
because of its good permeability to oxygen (29,30) and because
it has been widely used for implantable devices. A 5% PU
solution was selected to prepare these membranes as it pro¬
vided the possibility of adding an additional layer if the desired
characteristics were not obtained after the first deposit. If
the initial deposition results in a membrane that is too thick,
the sensor must be discarded. Because of the rapidity of this
deposition procedure, it was possible to put down a PU layer
without significantly disturbing the underlying enzyme and
CA membranes. Exposure of enzyme to organic solvents for
even minutes can cause significant loss of activity. Using this
new geometry and the new polymer deposition procedure, it
was possible to prepare these sensors at a success rate that
was better than 60% (n > 100).
Multilayer Permeabilities. One of the biggest challenges
for a hydrogen peroxide based glucose sensor is the elimination
of interferences resulting from the presence of electrochem-
ically active physiological compounds. Unfortunately, de-






























° Results are shown as mean ± SD for 20 sensors. bSerum levels.
c Apparent increase in glucose concentration when interfèrent is
added at physiological maximum. d ND, not detected.










°Reported for the sensors with upper limit of linear range > 15
mM. b Results are shown as mean ± SD for 20 sensors.
c Background currents were recorded after 1 h of polarization.
tection of hydrogen peroxide requires a rather high applied
potential. Any substance that is capable of being oxidized
at +600 mV at a platinum surface may possibly act as an
interfèrent. The list of such compounds normally found in
blood serum includes ascorbic acid, uric acid, and cysteine (31).
Acetaminophen has also been shown to give significant in¬
terferences at physiological levels (32). The subcutaneous
levels are not generally known and may differ from those in
blood.
One of the functions of the inner membrane covering the
platinum anode is to improve electrochemical selectivity of
the sensor by discriminating against such interferents. Since
both ascorbic acid and uric acid are negatively charged at
physiological pH, the presence of a negatively charged mem¬
brane such as CA on the electrode surface is very effective
in retarding such interferents. The response for various in¬
terferents is reported as the bias introduced by their presence
on the response of a glucose solution (Table II). The resulting
error was the percentage change of the sensor output in re¬
sponse to 5.5 mM glucose, when the concentration of inter¬
fering compound was varied from zero to its physiological
maximum. This represents the maximum possible error since
variation from zero to the maximum level is not normally
expected. As seen in Table II, the multilayer structure of the
sensor was very effective in minimizing the errors resulting
from the presence of most of the endogenous interferences.
Errors due to acetaminophen were sizable.
In Vitro Characteristics of the Sensor. The in vitro
characteristics of the sensor are given in Table III. Besides
being selective for glucose as discussed in the previous section,
the sensor response must also be linear or predictable from
1 to at least 15 mmol/L (33). One of the functions of the outer
polyurethane membrane is to reduce the flux of glucose to the
electrode surface and in turn extend the linear dynamic range.
The cost of improved linearity is an increase in response time
(which should be less than about 5-6 min) and a decrease in
sensitivity of the sensor. The sensors with an upper limit of
linear range between 15 and 20 mM showed sensitivities be¬
tween 1.2 and 3.4 nA mM"1 mm"2. The absolute background
currents were low (0.4-1 nA). Thus, the signal-to-background
ratio at normal glucose levels (5.5 mM) was between 7 and
10.
Stability of the Reference Electrode. The stability of
the reference electrode is an important consideration during
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Table IV. Effect of Applied Potential on Sensor Response
and Background Current
sensitivity response to
to glucose background H202, nA/0.
appl potential,0 V nA/mM current,6 nA mM
0.32 0.52 -0.1 2.5
0.45 0.59 0.2 3.9
0.50 0.65 0.2 4.0
0.60 0.65 0.4 4.0
0.72 0.69 1.5 3.8
0 Versus Ag/AgCl, 0.15 M Cl". b Background currents were re¬
corded after 30 min of polarization.
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Figure 3. Storage stability curves for two different sensors. The
sensors were stored in 0.1 M PBS, pH 7.4, at room temperature
between each calibration.
the in vitro evaluation of a sensor. For a two-electrode am-
perometric system, a variation in reference potential could
cause a change in sensor output depending, of course, on the
extent of the variation. There is a possibility that the potential
of the reference electrode could change due to flow of current
through it.
The potentials of the Ag/AgCl electrodes were monitored
during the operation of the sensor vs an external standard
reference electrode. The variation in potential under normal
operating conditions (4-600 mV, 37 °C, 5.5 mM glucose) was
found to be 3 ± 2 mV (n = 4) over a 12-h period. Considering
the fact that the sensor output was almost independent of the
applied potential over a wide potential range (Table IV), it
was reasonable to assume that such a small variation in the
reference potential would not affect the sensor response. As
a matter of fact, the drift in sensor output, expressed as a
percentage change in the sensor output, to 5.5 mM glucose
was found to be only 5 ± 2% (n = 4) over a 24-h period. The
potential of the reference electrode was also found to be in¬
dependent of output current in the 0-15 mM range.
Operational and Storage Stability. The storage stability
of these sensors was excellent. The polyurethane-coated
sensors showed an increase in response (and a corresponding
decrease in linearity) for the first few days following prepa¬
ration before reaching a stable value. This resulted from the
swelling of PU membranes as the residual solvents were re¬
placed with water during the conditioning process, increasing
their permeability to glucose. Figure 3 shows the results of
two typical experiments taken from more than 20 sensors, 80%
of which showed this behavior. The stabilization period was
usually between 3 and 7 days. The buffer treatment is also
an important step in removing the leachable toxic substances
such as residual organic solvents and excess glutaraldehyde
from a freshly prepared sensor, thus making the sensor non¬
toxic (22).
In order to check the operational stability of the sensor, the
sensor calibration was run daily over a 7-day period. Between
each calibration, the sensor was stored in a fresh solution
containing 5.5 mmol/L glucose at 37 °C. No change in sensor
response to glucose was observed during this period (Table
V). Owing to the storage procedure employed, the enzyme
was turning over continuously during the 7-day test. As no
potential was applied during the storage period, there was no
electrochemical depletion of hydrogen peroxide produced in
the enzyme layer. The observed stability of the sensor re¬
sponse under these conditions is quite encouraging because
hydrogen peroxide has been reported to denature immobilized
glucose oxidase (34). Both the linearity of the sensor and its
response to hydrogen peroxide were also maintained (Table
V), indicating that there was no change in membrane
permeability during the test period.
Effect of Temperature and pH. The temperature
coefficient was measured by changing the temperature of the
test solution from 30 to 42 °C. The output current for 5.5 mM
glucose increased by 2.5 ± 0.6% (n = 3) per 1 °C increase in
temperature. A small variation in body temperature, there¬
fore, during in vivo measurement is not expected to cause a
big error in the measurement. The output of the sensor was
also found to be stable in the pH range 7.2-7.8.
Effect of Hydrodynamics and Oxygen Tension. The
effect of stirring on sensor output was checked by turning a
magnetic stirrer on and off during the sensor calibration. The
sensor response was found to be essentially independent of
the stirring rate, indicating that diffusion of glucose through
the PU membrane is the rate-limiting step rather than the
enzymatic reaction. This characteristic of the sensor makes
it immune to the external depletion layer effects associated
with making measurements in unstirred solutions.
A commonly expressed concern for a glucose oxidase sensor
is that changing Po2 levels in the subcutaneous tissue may
effect the sensor output. The effect of oxygen tension on the
sensor output was checked by equilibrating the test buffer with
various air/nitrogen gas mixtures. The oxygen partial pres¬
sures were adjusted between 8 and 160 mmHg and were
monitored by an oxygen electrode.
For linear sensors (linearity > 15 mM), the response at 6
mM glucose was found to be completely independent of the
oxygen partial pressure of the test solution in the above-
mentioned range (8-160 mmHg). Even at the 15 mM glucose
level, the difference in sensor output for the two extreme Po,
levels was 3 ± 2% (n = 4). A nonlinear sensor (linearity <
7 mM), on the other hand, showed a strong dependence on
oxygen tension. Upon decreasing the oxygen pressure from
160 to 8 mmHg at 15 mM glucose, a 35% decrease in sensi¬
tivity was observed. The difference between a linear sensor
and a nonlinear sensor (assuming they have similar enzyme
loading) is that the linear sensor has a lower sensitivity and
its demand for oxygen is, therefore, substantially reduced. In
essence, the linearity is obtained by decreasing the glucose
flux to the active layer to such an extent that the enzymatic
activity far exceeds the substrate (glucose) supply. The overall
process is therefore controlled by the diffusion of glucose
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through the outer membrane. Our preliminary estimate of
the subcutaneous P0 levels at the sensor sites in a rat is in
the range of 8-25 mmHg (29), which is in agreement with the
previously reported (35) values (23.8 ± 5 mmHg, n = 16). The
A)2 of the subcutaneous tissue in man is higher than that
found in the rat and is similar to venous Po2 (35). These
results indicate that it is possible to design a sensor which is
virtually insensitive to changes in oxygen tension in the
physiologically relevant Pq2 range and also that polyurethane
restricts the diffusion of glucose while remaining relatively
permeable to oxygen. The above-mentioned results, however,
do not predict exactly how the sensor will respond to such low
oxygen levels during an in vivo experiment. In vivo experi¬
ments are currently underway to clarify this point.
Sensor Testing in Serum. Another important consid¬
eration for implantable sensors designed for long-term ap¬
plications is the sensor stability in the presence of biological
fluids.
The sensors were tested in the presence of three major
plasma proteins, namely albumin, 7-globulin, and fibrinogen,
which were added to the test buffer at their physiological
concentrations. Although the concentration of plasma proteins
in interstitial (subcutaneous) fluid is supposed to be low, a
higher concentration at the implantation site is possible as
a result of tissue /cell damage or as a result of inflammatory
processes. None of the proteins showed any effect on the
sensor output, even after an extended exposure of the sensor
to these proteins for several hours. Though these studies with
single proteins are not necessarily representative of the events
that might occur in the dynamic physiological environment,
we can still conclude that the various sensor membranes were
effective in excluding proteins from the electrode surface.
The sensors showed lower sensitivities in serum (bovine)
as compared to those in PBS. However, the observed sen¬
sitivity values in serum, which were only 70 ± 3% (n = 4) of
the sensitivities in PBS, were stable even after several days
of continuous contact of the sensor with serum under sterile
conditions. Also, this loss of sensitivity was reversible as the
sensors recovered their original sensitivities when tested in
PBS after they were removed from the serum and washed with
PBS. One possible reason for this loss may be that there are
compounds in the serum that adsorb and alter the permea¬
bility of the outer membrane. It was quite possible that this
adsorption process was initiated by some small compound
present in serum, as there was no inhibition from single-
protein solutions. Another possibility might be the inhibition
of the electrode surface by small ions or molecules. A recent
study, in which an electrochemical sensor was exposed to
various fractions of serum as obtained by ultrafiltration,
concludes that the removal of large proteins from serum is
not enough to completely prevent the poisoning of the sensor
(36). These results indicate that a decrease in sensitivity can
be expected upon implantation. This underlines the need for
in vivo calibration of the sensor and further studies to identify
the source of the apparently reversible "inhibition" process.
CONCLUSION
The performance characteristics of the sensor clearly meet
the requirements of an implantable glucose sensor. In addition
to the geometry, it is believed that the sensor fabrication
techniques also contribute significantly to its sensitivity and
stability. The technique involving the use of a wire loop makes
possible the application of the same amount of polymer to
the sensor each time in what appears to be a film of uniform
performance. The sensor geometry is compatible with sub¬
cutaneous implantation.
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